title: Impact of community-associated methicillin resistant Staphylococcus aureus on HIV-infected patients.
abstract: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged as an increasingly important pathogen, causing infections in persons who have no significant healthcare exposures. Persons with human immunodeficiency virus (HIV) infection have been disproportionately affected by CA-MRSA, with increased colonization and infection documented. Several factors are likely involved in the increased CA-MRSA burden observed among HIV-infected patients, including immune factors as well as healthcare and community exposures. Proposed community exposures that have been associated with increased CA-MRSA risk include substance abuse, incarceration, geographic area of residence, and social networks. This article explores these associations and reviews the current knowledge of the epidemiology, pathogenesis, clinical manifestations, and treatment of CA-MRSA in HIV-infected persons.
authors: Rush University Medical Center, 600 S Paulina Ste 140, Chicago, IL 60612, USA. Joanna_Cole@rush.edu
authors: Joanna
authors: J
authors: Cole
authors: Kyle
authors: K
authors: Popovich
mesh_terms: D015658:HIV Infections / Q000276:immunology / Q000382:microbiology*; D006801:Humans; D016867:Immunocompromised Host; D055624:Methicillin-Resistant Staphylococcus aureus; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000382:microbiology* / Q000517:prevention & control
references: J Acquir Immune Defic Syndr. 2010 Dec;55(4):466-72
references: 20686410
references: Clin Infect Dis. 2013 Apr;56(8):1067-74
references: 23325428
references: Clin Infect Dis. 2005 May 15;40(10):1429-34
references: 15844065
references: Antimicrob Agents Chemother. 2007 Jul;51(7):2628-30
references: 17502411
references: Clin Infect Dis. 2012 Feb 15;54(4):560-7
references: 22186773
references: BMC Infect Dis. 2011 Oct 19;11:279
references: 22011388
references: AIDS. 2011 Apr 24;25(7):1001-3
references: 21330913
references: J Infect Dis. 2005 Jun 15;191(12):2149-52
references: 15898002
references: J Infect Dis. 2010 Mar 15;201(6):843-54
references: 20144043
references: Infect Control Hosp Epidemiol. 2006 Feb;27(2):170-4
references: 16465633
references: J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):155-60
references: 16186732
references: Clin Infect Dis. 2008 Mar 1;46(5):752-60
references: 18220477
references: J Clin Microbiol. 2004 Jun;42(6):2398-402
references: 15184410
references: J Clin Microbiol. 2004 May;42(5):2080-4
references: 15131173
references: Infect Control Hosp Epidemiol. 2009 Jan;30(1):9-12
references: 19046052
references: Clin Infect Dis. 2004 Nov 15;39(10):1446-53
references: 15546080
references: BMC Infect Dis. 2011 Oct 31;11:298
references: 22040268
references: J Infect Dis. 2009 Jul 1;200(1):88-93
references: 19463064
references: Infect Control Hosp Epidemiol. 2011 Nov;32(11):1116-9
references: 22011540
references: Arch Intern Med. 2007 Apr 23;167(8):854-7
references: 17452552
references: J Clin Microbiol. 2007 Jul;45(7):2293-5
references: 17494715
references: J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):231-3
references: 18820536
references: N Engl J Med. 2005 Apr 7;352(14):1436-44
references: 15814879
references: JAMA. 1998 Feb 25;279(8):593-8
references: 9486753
references: J Clin Microbiol. 2007 Apr;45(4):1350-2
references: 17287335
references: J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):567-71
references: 18645516
references: Clin Infect Dis. 2007 Mar 15;44(6):777-84
references: 17304447
references: J Clin Microbiol. 2008 Oct;46(10):3222-7
references: 18685002
references: Clin Infect Dis. 2007 Jan 15;44(2):178-85
references: 17173213
references: Clin Infect Dis. 2012 May;54(9):1296-303
references: 22354926
references: Clin Infect Dis. 2004 May 1;38(9):e92-5
references: 15127360
references: J Infect Dis. 2007 Sep 15;196(6):911-8
references: 17703423
references: J Clin Microbiol. 2003 Nov;41(11):5113-20
references: 14605147
references: Am J Infect Control. 2008 Nov;36(9):644-50
references: 18834755
references: J Infect Dis. 2011 Aug 1;204(3):340-7
references: 21742831
references: Clin Microbiol Infect. 2010 May;16(5):425-31
references: 19689469
references: Clin Infect Dis. 2006 Mar 1;42(5):647-56
references: 16447110
references: J Infect Dis. 1999 Sep;180(3):896-9
references: 10438389
references: J Clin Microbiol. 2004 Sep;42(9):4050-3
references: 15364988
references: J Antimicrob Chemother. 2012 May;67(5):1267-70
references: 22311935
references: Infect Immun. 2010 Jan;78(1):32-8
references: 19901061
references: Clin Infect Dis. 2009 Jul 1;49(1):118-21
references: 19480576
references: N Engl J Med. 2006 Aug 17;355(7):666-74
references: 16914702
references: N Engl J Med. 2005 Apr 7;352(14):1445-53
references: 15814880
references: Eur J Dermatol. 2012 Nov-Dec;22(6):781-4
references: 23211678
references: Nat Med. 2007 Dec;13(12):1405-6
references: 18064027
references: N Engl J Med. 2008 Oct 9;359(15):e20
references: 18843122
references: Int J STD AIDS. 2007 Aug;18(8):521-6
references: 17686212
references: Drug Saf. 2012 Jun 1;35(6):447-57
references: 22612850
references: HIV Med. 2006 Sep;7(6):361-8
references: 16903980
references: N Engl J Med. 2002 Feb 14;346(7):491-6
references: 11844850
references: Arch Intern Med. 2007 May 28;167(10):1026-33
references: 17533205
references: HIV Med. 2008 Nov;9(10):858-62
references: 18754806
references: PLoS One. 2009 Nov 11;4(11):e7558
references: 19907649
references: Antimicrob Agents Chemother. 2010 Sep;54(9):3804-11
references: 20585117
references: Clin Infect Dis. 2005 May 15;40(10):1529-34
references: 15844078
references: PLoS Pathog. 2009 Dec;5(12):e1000703
references: 20041174
references: Clin Infect Dis. 2010 Apr 1;50(7):979-87
references: 20192731
references: Vaccine. 2012 Apr 19;30(19):2921-7
references: 22115633
references: AIDS Patient Care STDS. 2009 Jul;23(7):499-502
references: 19530952
references: J Infect Dis. 1991 Jun;163(6):1279-85
references: 2037793
references: Ann Intern Med. 2008 Feb 19;148(4):249-57
references: 18283202
references: Infect Control Hosp Epidemiol. 2000 Jul;21(7):459-64
references: 10926396
references: J Infect Dis. 2008 May 1;197(9):1226-34
references: 18422434
references: N Engl J Med. 2006 Aug 17;355(7):653-65
references: 16914701
references: Antimicrob Agents Chemother. 2007 Nov;51(11):4044-8
references: 17846141
references: Clin Infect Dis. 2004 Oct 1;39(7):971-9
references: 15472848
references: Clin Infect Dis. 2006 Jun 15;42(12):e108-10
references: 16705566
references: Lancet. 2006 Mar 4;367(9512):731-9
references: 16517273
references: Lancet Infect Dis. 2013 Jan;13(1):43-54
references: 23103172
references: N Engl J Med. 2002 Jun 13;346(24):1871-7
references: 12063371
references: Clin Infect Dis. 2012 Sep;55 Suppl 3:S173-80
references: 22903949
references: Clin Infect Dis. 2005 Jan 1;40(1):100-7
references: 15614698
references: J Clin Microbiol. 2012 Dec;50(12):4067-72
references: 23052313
references: Clin Infect Dis. 2007 Feb 1;44(3):410-3
references: 17205449
references: HIV Med. 2010 Jul 1;11(6):389-94
references: 20059572
references: Antimicrob Agents Chemother. 2007 Oct;51(10):3591-8
references: 17682105
references: Clin Infect Dis. 2012 Aug;55(4):582-6
references: 22615331
references: Clin Microbiol Rev. 1997 Jul;10(3):505-20
references: 9227864
references: Pediatr Infect Dis J. 2004 Feb;23(2):123-7
references: 14872177
references: Clin Infect Dis. 2011 Feb 1;52(3):e18-55
references: 21208910